Literature DB >> 25135702

Screening methodologies for the development of spray-dried amorphous solid dispersions.

Íris Duarte1, José Luís Santos, João F Pinto, Márcio Temtem.   

Abstract

PURPOSE: To present a new screening methodology intended to be used in the early development of spray-dried amorphous solid dispersions.
METHODS: A model that combines thermodynamic, kinetic and manufacturing considerations was implemented to obtain estimates of the miscibility and phase behavior of different itraconazole-based solid dispersions. Additionally, a small-scale solvent casting protocol was developed to enable a fast assessment on the amorphous stability of the different drug-polymer systems. Then, solid dispersions at predefined drug loads were produced in a lab-scale spray dryer for powder characterization and comparison of the results generated by the model and solvent cast samples.
RESULTS: The results obtained with the model enabled the ranking of the polymers from a miscibility standpoint. Such ranking was consistent with the experimental data obtained by solvent casting and spray drying. Moreover, the range of optimal drug load determined by the model was as well consistent with the experimental results.
CONCLUSIONS: The screening methodology presented in this work showed that a set of amorphous formulation candidates can be assessed in a computer model, enabling not only the determination of the most suitable polymers, but also of the optimal drug load range to be tested in laboratory experiments. The set of formulation candidates can then be further fine-tuned with solvent casting experiments using a small amount of API, which will then provide the decision for the final candidate formulations to be assessed in spray drying experiments.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135702     DOI: 10.1007/s11095-014-1457-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Evaluation of predictive models for stable solid solution formation.

Authors:  Jessica Albers; Karin Matthée; Klaus Knop; Peter Kleinebudde
Journal:  J Pharm Sci       Date:  2010-08-27       Impact factor: 3.534

2.  A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions.

Authors:  Dexi Lin; Yanbin Huang
Journal:  Int J Pharm       Date:  2010-08-18       Impact factor: 5.875

Review 3.  Evaluation of amorphous solid dispersion properties using thermal analysis techniques.

Authors:  Jared A Baird; Lynne S Taylor
Journal:  Adv Drug Deliv Rev       Date:  2011-08-04       Impact factor: 15.470

4.  Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture.

Authors:  Alfred C F Rumondor; Håkan Wikström; Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  AAPS PharmSciTech       Date:  2011-09-17       Impact factor: 3.246

Review 5.  Assessing the performance of amorphous solid dispersions.

Authors:  Ann Newman; Gregory Knipp; George Zografi
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

6.  Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.

Authors:  Kirk A Overhoff; Alejandro Moreno; Dave A Miller; Keith P Johnston; Robert O Williams
Journal:  Int J Pharm       Date:  2006-11-26       Impact factor: 5.875

7.  Solubility parameters as predictors of miscibility in solid dispersions.

Authors:  D J Greenhalgh; A C Williams; P Timmins; P York
Journal:  J Pharm Sci       Date:  1999-11       Impact factor: 3.534

8.  Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.

Authors:  Sandrien Janssens; Sophie Nagels; Hector Novoa de Armas; Ward D'Autry; Ann Van Schepdael; Guy Van den Mooter
Journal:  Eur J Pharm Biopharm       Date:  2007-11-19       Impact factor: 5.571

9.  Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).

Authors:  Patrick J Marsac; Alfred C F Rumondor; David E Nivens; Umesh S Kestur; Lia Stanciu; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

10.  Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends.

Authors:  Sandrien Janssens; Hector Novoa de Armas; Ward D'Autry; Ann Van Schepdael; Guy Van den Mooter
Journal:  Eur J Pharm Biopharm       Date:  2008-02-16       Impact factor: 5.571

View more
  5 in total

1.  The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range.

Authors:  Yiwei Tian; Kaijie Qian; Esther Jacobs; Esther Amstad; David S Jones; Lorenzo Stella; Gavin P Andrews
Journal:  Pharmaceutics       Date:  2019-08-19       Impact factor: 6.321

Review 2.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

3.  Prediction of Phase Behavior of Spray-Dried Amorphous Solid Dispersions: Assessment of Thermodynamic Models, Standard Screening Methods and a Novel Atomization Screening Device with Regard to Prediction Accuracy.

Authors:  Aymeric Ousset; Pierre-François Chavez; Joke Meeus; Florent Robin; Martin Alexander Schubert; Pascal Somville; Kalliopi Dodou
Journal:  Pharmaceutics       Date:  2018-03-07       Impact factor: 6.321

4.  Predicting process design spaces for spray drying amorphous solid dispersions.

Authors:  Stefanie Dohrn; Pranay Rawal; Christian Luebbert; Kristin Lehmkemper; Samuel O Kyeremateng; Matthias Degenhardt; Gabriele Sadowski
Journal:  Int J Pharm X       Date:  2021-02-25

Review 5.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.